Michelle S Ginsberg Selected Research

Michelle S Ginsberg Research Topics

Disease

27	Neoplasms (Cancer) 11/2021 - 01/2002
20	Lung Neoplasms (Lung Cancer) 04/2022 - 01/2002
12	Adenocarcinoma of Lung 01/2022 - 03/2009
10	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021 - 01/2002
10	Renal Cell Carcinoma (Grawitz Tumor) 09/2013 - 02/2003
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2010
4	Disease Progression 01/2020 - 12/2011
4	Malignant Mesothelioma 07/2019 - 06/2014
4	Adenocarcinoma 04/2016 - 03/2005
3	Fatigue 01/2016 - 12/2010
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 02/2012 - 10/2007
2	Hemorrhage 01/2022 - 03/2009
2	Pulmonary Embolism 11/2018 - 06/2008
2	Anemia 01/2016 - 06/2006
2	Embolism (Embolus) 09/2014 - 11/2002
2	Rectal Neoplasms (Rectal Cancer) 08/2013 - 05/2008
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 02/2012 - 12/2011
2	Stomatitis 05/2007 - 06/2003
1	Heart Neoplasms 01/2021
1	COVID-19 12/2020
1	Thrombosis (Thrombus) 06/2020
1	Mesothelioma 07/2019
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Cysts 01/2017
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2016
1	Leukopenia 01/2016
1	Edema (Dropsy) 01/2016
1	Pleural Effusion (Pleural Effusions) 01/2016
1	Sarcoma (Soft Tissue Sarcoma) 01/2016
1	Glioblastoma (Glioblastoma Multiforme) 11/2014
1	Hemoptysis 08/2013
1	Thymus Neoplasms (Thymus Neoplasm) 07/2013
1	Carcinoma (Carcinomatosis) 09/2012
1	Brain Neoplasms (Brain Tumor) 02/2012

Drug/Important Bio-Agent (IBA)

10	Sunitinib (Sutent)FDA Link 09/2013 - 01/2006
8	ErbB Receptors (EGF Receptor)IBA 01/2016 - 03/2009
7	Tyrosine Kinase InhibitorsIBA 01/2020 - 03/2009
7	Gefitinib (Iressa)FDA Link 07/2011 - 12/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2012 - 01/2006
5	Erlotinib Hydrochloride (CP 358,774)FDA Link 07/2011 - 09/2007
4	Bevacizumab (Avastin)FDA Link 01/2016 - 03/2009
3	Biomarkers (Surrogate Marker)IBA 04/2022 - 02/2012
3	Pemetrexed (MTA)FDA Link 04/2016 - 06/2014
3	Cisplatin (Platino)FDA LinkGeneric 04/2016 - 10/2007
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2016 - 05/2007
2	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2022 - 01/2016
2	GadoliniumIBA 01/2021 - 06/2020
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2009
2	CrizotinibIBA 01/2017 - 08/2015
2	cabozantinibIBA 12/2016 - 08/2015
2	Vinorelbine (Navelbine)FDA LinkGeneric 04/2016 - 06/2014
2	Docetaxel (Taxotere)FDA Link 04/2016 - 05/2007
2	Gemcitabine FDA Link 04/2016 - 06/2014
2	Anaplastic Lymphoma KinaseIBA 01/2016 - 11/2014
2	MethyltransferasesIBA 11/2014 - 02/2012
2	DNA (Deoxyribonucleic Acid)IBA 11/2014 - 02/2012
2	Temozolomide (Temodar)FDA LinkGeneric 11/2014 - 02/2012
2	Everolimus FDA Link 04/2012 - 12/2011
2	TOR Serine-Threonine KinasesIBA 04/2012 - 12/2011
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2012 - 01/2006
2	obatoclaxIBA 12/2011 - 11/2010
2	Topotecan (Hycamtin)FDA LinkGeneric 12/2011 - 11/2010
2	Pharmaceutical PreparationsIBA 08/2011 - 09/2007
2	Cetuximab (Erbitux)FDA Link 04/2011 - 02/2003
2	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 12/2010 - 01/2006
1	ponatinibIBA 01/2022
1	trametinibIBA 01/2022
1	Angiogenesis InhibitorsIBA 01/2020
1	IodineIBA 11/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	human ERBB2 proteinIBA 01/2018
1	Transaminases (Aminotransferases)IBA 01/2018
1	Ado-Trastuzumab EmtansineIBA 01/2018
1	Protein Subunit VaccinesIBA 12/2017
1	antineoplaston A10 (A 10)IBA 12/2016
1	Carboplatin (JM8)FDA LinkGeneric 04/2016
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2016
1	PlatinumIBA 01/2016
1	Alanine Transaminase (SGPT)IBA 01/2016
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2016
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2016
1	Alkylating AgentsIBA 11/2014
1	Fluorine-18IBA 10/2014
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 09/2014
1	Isoflurophate (DFP)FDA Link 09/2012
1	Sorafenib (BAY 43-9006)FDA Link 12/2011
1	farnesylthiosalicylic acidIBA 08/2011

Therapy/Procedure

17	Therapeutics 01/2020 - 01/2002
9	Drug Therapy (Chemotherapy) 10/2016 - 01/2002
5	Radiotherapy 01/2020 - 10/2014
4	Immunotherapy 11/2021 - 09/2017
4	Neoadjuvant Therapy 04/2016 - 05/2008
2	Chemoradiotherapy 01/2021 - 05/2008
2	Ambulatory Care (Outpatient Care) 12/2020 - 06/2008
1	Catheters 06/2020
1	Central Venous Catheters 06/2020
1	Pneumonectomy (Lung Volume Reduction) 10/2016
1	Contraindications 01/2016
1	Adjuvant Chemotherapy 08/2013
1	Thymectomy 07/2013